医学
2019年冠状病毒病（COVID-19）
严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）
2019-20冠状病毒爆发
病毒学
业务
内科学
疾病
爆发
传染病（医学专业）
作者
Fernando P. Polack,Stephen J. Thomas,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,John L. Perez,Gonzalo Pérez Marc,Edson Duarte Moreira,Cristiano A. F. Zerbini,Ruth Bailey,Kena A. Swanson,Satrajit Roychoudhury,Kenneth Koury,Ping Li,Warren V. Kalina,David Cooper,Robert W. Frenck,Laura L Hammitt,Özlem Türeci
标识
DOI：10.1056/nejmoa2034577
摘要
A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
Copyright
yjh123
Kao
temp
Moonpie
Avalonx
OK
小小
烟消云散
疯狂加载ing
sagitar
cdercder
yl666
Nexus
乐空思
小透明
火星上的菲鹰
科研狗
WW
皖公网安备34019202002308
